Aspirin in diabetic retinopathy
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Aspirin in Diabetic Retinopathy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450295/all/Aspirin_in_diabetic_retinopathy.
Aspirin in diabetic retinopathy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450295/all/Aspirin_in_diabetic_retinopathy. Accessed October 20, 2019.
Aspirin in diabetic retinopathy. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/450295/all/Aspirin_in_diabetic_retinopathy
Aspirin in Diabetic Retinopathy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450295/all/Aspirin_in_diabetic_retinopathy.
TY - ELEC
T1 - Aspirin in diabetic retinopathy
ID - 450295
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450295/all/Aspirin_in_diabetic_retinopathy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine